Skip to content

Imunon, Inc.: 10-K filed 2015-03-12

What Imunon, Inc. reported in its annual report filed 2015-03-12 (fiscal FY 2014): 36 published measures, 96 facts as tagged in accession 0001437749-15-004805.

This filing

Form
10-K (annual report)
Filed
2015-03-12
Fiscal period
fiscal FY 2014
Accession
0001437749-15-004805 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Imunon, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-12-3166,694,532USD
At 2013-12-3145,670,572USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-12-3133,869,196USD
At 2013-12-3114,146,737USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-12-3132,825,336USD
At 2013-12-3131,523,835USD
At 2012-12-3111,961,858USD
At 2011-12-3126,193,568USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-12-3112,686,881USD
At 2013-12-315,718,504USD
At 2012-12-3114,991,488USD
At 2011-12-3120,145,854USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-25,494,273USD365
2013-01-01 to 2013-12-31-8,251,358USD365
2012-01-01 to 2012-12-31-26,568,382USD366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-21,353,020USD365
2013-01-01 to 2013-12-31-9,525,276USD365
2012-01-01 to 2012-12-31-22,144,193USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-12-31672,256USD365
2013-01-01 to 2013-12-3157,494USD365
2012-01-01 to 2012-12-31613,390USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-12-3118,777,920USD365
2013-01-01 to 2013-12-3129,388,470USD365
2012-01-01 to 2012-12-3115,518,984USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-01-01 to 2014-12-319,543,477USD365
2013-01-01 to 2013-12-31-29,136,178USD365
2012-01-01 to 2012-12-311,470,843USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-12-31-195,073,702USD
At 2013-12-31-169,287,157USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-12-311,170,497USD
At 2013-12-31832,886USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-12-312,585,132USD365
2013-01-01 to 2013-12-311,235,437USD365
2012-01-01 to 2012-12-311,143,764USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-24,715,194USD365
2013-01-01 to 2013-12-31-15,411,485USD365
2012-01-01 to 2012-12-31-22,142,717USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-12-3137,506,271USD
At 2013-12-3143,762,119USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-12-3110,090,821USD
At 2013-12-314,670,980USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-12-313,480,225USD
At 2013-12-311,452,436USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2014-12-311,976,101USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-01-01 to 2014-12-3125,215,194USD365
2013-01-01 to 2013-12-3115,911,485USD365
2012-01-01 to 2012-12-3122,142,717USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-01-01 to 2014-12-3114,969,382USD365
2013-01-01 to 2013-12-319,364,228USD365
2012-01-01 to 2012-12-3115,770,166USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-12-3119,984,203shares
At 2013-12-3113,604,975shares
At 2013-10-3013,604,975shares
At 2013-10-2961,226,873shares
At 2013-10-282shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-12-31-16,032USD
At 2013-12-31-44,166USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-12-312,804,014USD
At 2013-12-312,097,076USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-12-311,633,517USD
At 2013-12-311,264,190USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-12-31286,592USD
At 2013-12-31472,731USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-12-312,456,365USD
At 2013-12-312,707,653USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-12-31235,133USD
At 2013-12-31563,551USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-25,466,139USD365
2013-01-01 to 2013-12-31-8,168,917USD365
2012-01-01 to 2012-12-31-26,418,289USD366

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-25,494,273USD365
2013-01-01 to 2013-12-31-12,852,768USD365
2012-01-01 to 2012-12-31-26,568,382USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-12-318,860,549USD365
2013-01-01 to 2013-12-316,547,257USD365
2012-01-01 to 2012-12-316,372,551USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-01-01 to 2014-12-31369,000USD365
2013-01-01 to 2013-12-31339,000USD365
2012-01-01 to 2012-12-31281,500USD366

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2014-01-01 to 2014-12-31369,327USD365
2013-01-01 to 2013-12-31339,229USD365
2012-01-01 to 2012-12-31281,489USD366

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-01-01 to 2014-12-317,500USD365
2013-01-01 to 2013-12-317,500USD365
2012-01-01 to 2012-12-317,500USD366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-01-01 to 2014-12-3151,937USD365
2013-01-01 to 2013-12-31-2,530USD365
2012-01-01 to 2012-12-31-1,040USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-779,079USD365
2013-01-01 to 2013-12-317,160,127USD365
2012-01-01 to 2012-12-31-4,425,665USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-01-01 to 2014-12-3113,788,811USD365
2013-01-01 to 2013-12-3115,622,955USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-311,764,563USD365
2013-01-01 to 2013-12-31-887,332USD365
2012-01-01 to 2012-12-31-1,344,379USD366

Inspect the source

Entity
Imunon, Inc. / CIK 0000749647
Captured
2026-09-19T15:01:50.763Z
SEC response SHA-256
cf2e46071525a607b4d539753f5129368297f1e667d6fa4f8829e76132e7a85a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000749647.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))